Cargando…

Short-time repeat high-risk HPV testing by self-sampling for screening of cervical cancer

BACKGROUND: Testing for high-risk human papillomavirus (HPV) in primary screening for cervical cancer is considered more sensitive, but less specific, in comparison with Pap-smear cytology. Women with persistent HPV infections have a higher risk of developing cervical intraepithelial neoplasia 2+ (C...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gyllensten, U, Sanner, K, Gustavsson, I, Lindell, M, Wikström, I, Wilander, E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2011
Materias:	Molecular Diagnostics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3188941/ https://www.ncbi.nlm.nih.gov/pubmed/21811250 http://dx.doi.org/10.1038/bjc.2011.277

Ejemplares similares

High viral loads of human papillomavirus predict risk of invasive cervical carcinoma
por: Moberg, M, et al.
Publicado: (2005)

Self-sampling and HPV testing or ordinary Pap-smear in women not regularly attending screening: a randomised study
por: Wikström, I, et al.
Publicado: (2011)

Self-sampling of the vaginal fluid at home combined with high-risk HPV testing
por: Sanner, K, et al.
Publicado: (2009)

HPV viral load in self-collected vaginal fluid samples as predictor for presence of cervical intraepithelial neoplasia
por: Berggrund, Malin, et al.
Publicado: (2019)

Cost-effectiveness analysis of repeated self-sampling for HPV testing in primary cervical screening: a randomized study
por: Aarnio, Riina, et al.
Publicado: (2020)

Cervical dysplasia in elderly women performing repeated self-sampling for HPV testing
por: Lindström, Annika Kristina, et al.
Publicado: (2018)

FAM19A4 methylation analysis in self-samples compared with cervical scrapes for detecting cervical (pre)cancer in HPV-positive women
por: Luttmer, Roosmarijn, et al.
Publicado: (2016)

HPV testing in routine cervical screening: cross sectional data from the ARTISTIC trial
por: Kitchener, H C, et al.
Publicado: (2006)

High-risk HPV type-specific clearance rates in cervical screening
por: Bulkmans, N W J, et al.
Publicado: (2007)

Age-specific prevalence of HPV genotypes in cervical cytology samples with equivocal or low-grade lesions
por: Brismar-Wendel, S, et al.
Publicado: (2009)

Type distribution, viral load and integration status of high-risk human papillomaviruses in pre-stages of cervical cancer (CIN)
por: Andersson, S, et al.
Publicado: (2005)

Randomised study shows that repeated self-sampling and HPV test has more than two-fold higher detection rate of women with CIN2+ histology than Pap smear cytology
por: Gustavsson, Inger, et al.
Publicado: (2018)

Temporal changes in the vaginal microbiota in self-samples and its association with persistent HPV16 infection and CIN2+
por: Berggrund, Malin, et al.
Publicado: (2020)

HPV testing as a triage for borderline or mild dyskaryosis on cervical cytology: results from the Sentinel Sites study
por: Kelly, R S, et al.
Publicado: (2011)

The role of miRNAs in human papilloma virus (HPV)-associated cancers: bridging between HPV-related head and neck cancer and cervical cancer
por: Lajer, C B, et al.
Publicado: (2012)

Human papillomavirus, p16(INK4A), and Ki-67 in relation to clinicopathological variables and survival in primary carcinoma of the vagina
por: Hellman, K, et al.
Publicado: (2014)

Clinical validation of the HPVIR high-risk HPV test on cervical samples according to the international guidelines for human papillomavirus DNA test requirements for cervical cancer screening
por: Gustavsson, Inger, et al.
Publicado: (2019)

Uneven distribution of human papillomavirus 16 in cervical carcinoma in situ and squamous cell carcinoma in older females: A retrospective database study
por: ANDERSSON, SONIA, et al.
Publicado: (2014)

Increased phosphorylation of p70 S6 kinase is associated with HPV16 infection in cervical cancer and esophageal cancer
por: Zhou, Y, et al.
Publicado: (2007)

Multi-site study of HPV type-specific prevalence in women with cervical cancer, intraepithelial neoplasia and normal cytology, in England
por: Howell-Jones, R, et al.
Publicado: (2010)

HPV in exhaled breath condensate of lung cancer patients
por: Carpagnano, G E, et al.
Publicado: (2011)

MCM immunocytochemistry as a first line cervical screening test in developing countries: a prospective cohort study in a regional cancer centre in India
por: Mukherjee, G, et al.
Publicado: (2007)

Telomerase activity as an adjunct to high-risk human papillomavirus types 16 and 18 and cytology screening in cervical cancer
por: Kailash, U, et al.
Publicado: (2006)

Serum antibodies to the HPV16 proteome as biomarkers for head and neck cancer
por: Anderson, K S, et al.
Publicado: (2011)

HPV molecular detection from urine versus cervical samples: an alternative for HPV screening in indigenous populations
por: Torres-Rojas, Francisco I., et al.
Publicado: (2021)

Epithelial-mesenchymal transition-like events in vulvar cancer and its relation with HPV
por: Rodrigues, I S, et al.
Publicado: (2013)

Benefit of chemotherapy as part of treatment for HPV DNA-positive but p16-negative squamous cell carcinoma of the oropharynx
por: Junor, E, et al.
Publicado: (2012)

Tumours with loss of MSH6 expression are MSI-H when screened with a pentaplex of five mononucleotide repeats
por: You, J-F, et al.
Publicado: (2010)

Expression of p16 in squamous cell carcinoma of the mobile tongue is independent of HPV infection despite presence of the HPV-receptor syndecan-1
por: Sgaramella, N, et al.
Publicado: (2015)

The HPV16 E6 binding protein Tip-1 interacts with ARHGEF16, which activates Cdc42
por: Oliver, A W, et al.
Publicado: (2011)

Nuclear survivin expression is associated with HPV-independent carcinogenesis and is an indicator of poor prognosis in oropharyngeal cancer
por: Preuss, S F, et al.
Publicado: (2008)

Cost and logistics of alternative roll-out options for implementing human papillomavirus testing as a triage in cervical screening: results of the sentinel sites study
por: Legood, R, et al.
Publicado: (2012)

Molecular profiling of cervical cancer progression
por: Hagemann, T, et al.
Publicado: (2007)

Tumour-infiltrating lymphocytes predict for outcome in HPV-positive oropharyngeal cancer
por: Ward, M J, et al.
Publicado: (2014)

A four-kallikrein panel for the prediction of repeat prostate biopsy: data from the European Randomized Study of Prostate Cancer Screening in Rotterdam, Netherlands
por: Gupta, A, et al.
Publicado: (2010)

Expression of IP-10 related to angiogenesis in uterine cervical cancers
por: Sato, E, et al.
Publicado: (2007)

Comparison and combination of blood-based inflammatory markers with faecal occult blood tests for non-invasive colorectal cancer screening
por: Tao, S, et al.
Publicado: (2012)

Validation of a novel diagnostic standard in HPV-positive oropharyngeal squamous cell carcinoma
por: Schache, A G, et al.
Publicado: (2013)

Epithelial to mesenchymal transition and HPV infection in squamous cell oropharyngeal carcinomas: the papillophar study
por: Lefevre, Marine, et al.
Publicado: (2017)

Evaluation of serum CEA, CYFRA21-1 and CA125 for the early detection of colorectal cancer using longitudinal preclinical samples
por: Thomas, D S, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_1psah4ee4jthqblmj8oi9b5t87